BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35547733)

  • 1. The Clinical Value of Procalcitonin in the Neutropenic Period After Allogeneic Hematopoietic Stem Cell Transplantation.
    Shan M; Shen D; Song T; Xu W; Qiu H; Chen S; Han Y; Tang X; Miao M; Sun A; Wu D; Xu Y
    Front Immunol; 2022; 13():843067. PubMed ID: 35547733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of sepsis biomarkers in hematopoietic stem cell transplant recipients in a condition of high prevalence of gram-negative pathogens.
    Stoma I; Karpov I; Uss A; Rummo O; Milanovich N; Iskrov I
    Hematol Oncol Stem Cell Ther; 2017 Mar; 10(1):15-21. PubMed ID: 27793578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factor for death in hematopoietic stem cell transplantation: are biomarkers useful to foresee the prognosis in this population of patients?
    Massaro KS; Macedo R; de Castro BS; Dulley F; Oliveira MS; Yasuda MA; Levin AS; Costa SF
    Infection; 2014 Dec; 42(6):1023-32. PubMed ID: 25263811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective evaluation of procalcitonin in adults with non-neutropenic fever after allogeneic hematopoietic stem cell transplantation.
    Ortega M; Rovira M; Filella X; Martínez JA; Almela M; Puig J; Carreras E; Mensa J
    Bone Marrow Transplant; 2006 Mar; 37(5):499-502. PubMed ID: 16415895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of serum procalcitonin and C-reactive protein for infections after allogeneic hematopoietic stem cell transplantation versus nontransplant setting.
    Mori Y; Miyawaki K; Kato K; Takenaka K; Iwasaki H; Harada N; Miyamoto T; Akashi K; Teshima T
    Intern Med; 2011; 50(19):2149-55. PubMed ID: 21963733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of risk factors related to the prognosis in patients with late-onset severe pneumonia after allogeneic hematopoietic stem cell transplantation].
    Chen Y; Wang Y; Jiang ZH; Xu LP; Zhang XH; Chen H; Chen YY; Wang FR; Wang JZ; Han W; Zhang YY; Han TT; Tang FF; Mo XD; Sun YQ; Yan CH; Liu KY; Huan XJ
    Zhonghua Nei Ke Za Zhi; 2017 Nov; 56(11):804-809. PubMed ID: 29136708
    [No Abstract]   [Full Text] [Related]  

  • 7. Pre-transplant CRP-albumin ratio as a biomarker in patients receiving haploidentical allogeneic hematopoietic transplantation: Developing a novel DRCI-based nomogram.
    Wang K; Jian X; Xu Z; Wang H
    Front Immunol; 2023; 14():1128982. PubMed ID: 36875097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective evaluation of procalcitonin in adults with febrile neutropenia after haematopoietic stem cell transplantation.
    Ortega M; Rovira M; Filella X; Almela M; Puig de la Bellacasa J; Carreras E; Mensa J
    Br J Haematol; 2004 Aug; 126(3):372-6. PubMed ID: 15257709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical predictive model for pre-transplantation
    Zhang Y-Q; Wu W-Q; Xu J; Tang Z-X; Li S-J; Li L; Wu H-Q; Ma X; Liu J-S; Wu D-P; Wu X-J
    Microbiol Spectr; 2024 Feb; 12(2):e0203923. PubMed ID: 38189331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum procalcitonin as an independent diagnostic markers of bacteremia in febrile patients with hematologic malignancies.
    Yang M; Choi SJ; Lee J; Lee DG; Kim YJ; Park YJ; Oh EJ
    PLoS One; 2019; 14(12):e0225765. PubMed ID: 31821331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the diagnostic value of procalcitonin and C-reactive protein after hematopoietic stem cell transplantation: a systematic review and meta-analysis.
    Lyu YX; Yu XC; Zhu MY
    Transpl Infect Dis; 2013 Jun; 15(3):290-9. PubMed ID: 23387529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Procalcitonin with the Patient's Infection Characteristics and Prognosis after Hematopoietic Stem Cell Transplantation.
    Li SS; Gu JX; Li XW; Zhang N; Jia M; Pei L; Su M
    Dis Markers; 2022; 2022():9157396. PubMed ID: 36148158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of procalcitonin and C-reactive protein as infection markers in febrile neutropenic patients undergoing haematopoietic stem cell transplant].
    Sánchez-Yepes M; Aznar-Oroval E; Lorente-Alegre P; García-Lozano T; Picón-Roig I; Pérez-Ballestero P; Ortiz-Muñoz B
    Enferm Infecc Microbiol Clin; 2014; 32(7):418-23. PubMed ID: 24269102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of procalcitonin and critical illness score in etiological diagnosis and prognosis of sepsis caused by intra-abdominal infections].
    Yan S; Lian R; Sun L; Jin Z; Zhao C; Zhang G
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Jul; 33(7):792-797. PubMed ID: 34412746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical role of procalcitonin in hematopoietic SCT.
    Koya J; Nannya Y; Ichikawa M; Kurokawa M
    Bone Marrow Transplant; 2012 Oct; 47(10):1326-31. PubMed ID: 22343672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of specific pathogens to bloodstream infection mortality in neutropenic patients with hematologic malignancies: Results from a multicentric surveillance cohort study.
    Kern WV; Roth JA; Bertz H; Götting T; Dettenkofer M; Widmer AF; Theilacker C;
    Transpl Infect Dis; 2019 Dec; 21(6):e13186. PubMed ID: 31574202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The application value of the procalcitonin clearance rate on therapeutic effect and prognosis of ventilator associated pneumonia].
    Abula A; Wang Y; Ma L; Yu X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Nov; 26(11):780-4. PubMed ID: 25399890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Routine Use of Biomarkers to Rationalize Antibiotic Use During Febrile Episodes in Pediatric Bone Marrow Transplantation Units.
    Toro JF; Peña E; Ramírez O; López P; Portilla CA; López-Medina E
    Pediatr Infect Dis J; 2021 Nov; 40(11):1023-1028. PubMed ID: 34636797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical utility of procalcitonin in bacterial infections in patients undergoing hematopoietic stem cell transplantation.
    Bansal A; Jeyaraman P; Gupta SK; Dayal N; Naithani R
    Am J Blood Res; 2020; 10(6):339-344. PubMed ID: 33489442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral microorganisms and bloodstream infection in allogeneic hematopoietic stem cell transplantation.
    Ohbayashi Y; Imataki O; Uemura M; Takeuchi A; Aoki S; Tanaka M; Nakai Y; Nakai F; Miyake M
    Clin Oral Investig; 2021 Jul; 25(7):4359-4367. PubMed ID: 33392808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.